MD
Michael D Dale (Chief Executive Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Axogen, Inc. (AXGN). The largest single filing was $1.9M of AXGN (61,463 sh × $31.21, as filed), executed Dec 9 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.7M
shares × price, as filed
Last traded
Dec 10 2025
Filed Dec 12 2025
Median ADV $60.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
AXGNRecent filings
AXGNSALE
Axogen, Inc.
View filing →
$750K25,000 sh × $30.00
Exec Dec 10 2025
Filed Dec 12 2025 · 5:30 PM ET AXGNSALE Axogen, Inc. View filing → $1.9M
61,463 sh × $31.21
Exec Dec 9 2025
Filed Dec 10 2025 · 5:30 PM ET